Canonical ingredient

Acetamide, N-(4-hydroxyphenyl)-

ACETAMINOPHEN

1,299 linked products

Official identifiers

CAS 103-90-2 NHPID_ID 4766

Names and synonyms

Acetamide, N-(4-hydroxyphenyl)- (en)
Acétaminophène (fr)
Paracétamol (fr-CA)

Source-scoped chemical properties

Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.

canada dsl listing: listed; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl bioaccumulative: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl inherently toxic aquatic: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets cepa categorization: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets environmental: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets human health: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl persistent: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl substance category: Organics; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03

Equivalent concepts in other registries

These links require an exact shared identifier; names alone are never sufficient.

paracetamol
GLOBAL · CAS 103-90-2
Verification source

Safety and technical documents

General references and manufacturer-specific SDS documents are kept separate.

0 document(s)

No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.

End-to-end traceability

Only links supported by an identified source are published. Missing evidence remains explicitly unknown.

Partial chain

Classification hierarchy

Acétaminophène

Evidence still missing

Country or region of origin
Transformation steps

Documented origins

No origin has been proven yet by an explicit source.

Documented organizations

ARA - Avanti Rx Analytics Inc. - Product owner (licence holder)Source
AURO PHARMA INC - Product owner (licence holder)Source
CATALENT ONTARIO LIMITED - Product owner (licence holder)Source
FORTUNE PHARMACAL CO. LTD. - Product owner (licence holder)Source
GLAXOSMITHKLINE INC - Product owner (licence holder)Source
PATHEON LABORATORIES - Product owner (licence holder)Source
PATRIOT A DIVISION OF JANSSEN INC - Product owner (licence holder)Source
RANBAXY PHARMACEUTICALS CANADA INC. - Product owner (licence holder)Source
SHOPPERS DRUG MART INC. - Product owner (licence holder)Source
SIVEM PHARMACEUTICALS ULC - Product owner (licence holder)Source
SMITHKLINE CONSUMER PRODUCTS - Product owner (licence holder)Source
THERAPEX DIVISION DE E-Z-EM CANADA INC - Product owner (licence holder)Source

Documented transformations

No transformation step has been proven yet by an explicit source.

Method: a company’s registration country is never used as evidence of a material’s origin.

Products containing this ingredient

(EXTRA STRENGTH) ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE CAPLETS

222 AF EXTRA STRENGTH CAPLET (500MG)

222 AF REGULAR STRENGTH CAPLET (325MG)

222AF EXTRA STRENGTH 500MG

222AF REGULAR STRENGTH 325MG

A.F. ANACIN TABLETS 325MG

A.F.ANACIN EXTRA STRENGTH TABLETS

A.M. COLD RELIEF FORMULA

ACET CODEINE 30

ACET CODEINE 60

ACETAB TAB 325MG

325 · MG · TAB

325 · MG · SUP

650 · MG · SUP

160 · MG · 5 · ML

80 · MG · 5 · ML

ACETAMINOPHEN 160 MG CHEWABLE TABLETS

ACETAMINOPHEN 160 MG CHILDREN ELIXIR USP

160 · MG · 5 · ML

ACETAMINOPHEN 160MG CHILDREN LIQUID SUSPENSION USP

160 · MG · 5 · ML

ACETAMINOPHEN 300MG, CAFFEINE & CODEINE

ACETAMINOPHEN 325 MG

ACETAMINOPHEN 325 MG

ACETAMINOPHEN 325 MG CAFFEINE AND CODEINE

ACETAMINOPHEN 325 MG TABLETS

ACETAMINOPHEN 325 MG USP

ACETAMINOPHEN 325 MG USP REGULAR STRENGTH

ACETAMINOPHEN 325 MG WITH 15 MG CAFFEINE AND 8 MG CODEINE PHOSPHATE

ACETAMINOPHEN 325MG

325 · MG · TAB